Skip to content
DataLookout
Menu

NCT06045572

Vascular Supply Identification, Lesion Extension and Search for Tumor Similarity at a Distance by VTM in Breast Cancer

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 5 with changes below, 1 re-verified with no change.

  1. Notable Primary completion pushed from Jun 1, 2026 to May 1, 2027
    • Start date: Jun 1, 2026 to May 1, 2027
    • Study completion pushed from Jun 1, 2027 to May 1, 2028
    • Secondary endpoints: details revised at 8 of 12 entries
  2. Notable Primary completion date: Jun 2025 to Jun 1, 2026
    • Start date: Feb 2025 to Jun 1, 2026
    • Study completion date: Nov 2025 to Jun 1, 2027
    v5
  3. Notable Primary completion date: Sep 2024 to Jun 2025
    • Start date: Apr 2024 to Feb 2025
    • Study completion date: Nov 2024 to Nov 2025
    v4
  4. Notable Primary completion date: Nov 30, 2023 to Sep 2024
    • Start date: Oct 1, 2023 to Apr 2024
    • Study completion date: May 1, 2024 to Nov 2024
    v3
  5. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Concordance of the diagnosis of abnormality during the VTM exam in relation to the standard exam (mammography);
Timeframe: [D2, approximately 60 days]
Frequency of non-visible vascular identification:
Timeframe: [D2, approximately 60 days]
Frequency of identifying non-visible textures
Timeframe: [D2, approximately 60 days]
Frequency of thermal discrepancy in nearby pixels in areas suspected of non-visible abnormalities:
Timeframe: [D2, approximately 60 days]
Frequency of sample changes detected by VTM
Timeframe: [D2, approximately 60 days]

Secondary (11)

(ClinROs) Diagnostic image quality by VTM in pathological changes of the breast;
(ClinROs) Ease of use and functionality;
(ClinROs) Image acquisition time;
(PROs) Discomfort during the VTM exam;
(PROs) Pain during VTM exam;
Show 6 moreShow less
(PROs) Importance of the VTM exam research to the participant;
Frequency of adverse events, unexpected adverse events, and serious adverse events (discrete numerical and categorical yes/no);
All-cause mortality rate during the study;
Tolerability of the VTM exam;
Demographic data analysis;
Prospective data.

Arms and interventions

women diagnosed with breast cancer before cancer treatmentExperimental

Devices: VTM examination and breast biopsy